Modalis Therapeutics Corporation (4883.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

JPY 3.11B

MomentumView details →

1D Return

+2.94%

YTD Return

−37.50%

RSI (14)

59.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

JPY 3.11B

RSI (14)

59.9

MomentumView details →

1D Return

+2.94%

YTD Return

−37.50%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−65.13%

ROA (TTM)

−61.96%

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

+23.82%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+2.49%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

25.02x

Quick Ratio

25.02x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

−1.82B

Op. CF (TTM)

—

Next earningsNov 11, 2026 →

Latest newsMore news →

No recent news for 4883.T.

Similar companies

SymBio Pharmaceuticals Limited4582.T Kringle Pharma,Inc.4884.T Veritas In Silico Inc.130A.T MUROMACHI CHEMICALS INC.4885.T Medrx Co.,Ltd.4586.T Kubota Pharmaceutical Holdings Co.,Ltd.4596.T Find similar companies →

Latest newsMore news →

No recent news for 4883.T.